Niels Jacobsen - Demant AS Deputy Chairman of the Board

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>DA</div>
Mr. Niels Jacobsen was Deputy Chairman of the Board of William Demant Holding AS since March 27, 2017. He no longer serves as Chief Executive Officer, President and Member of the Executive Board of the Company, effective as of April 1, 2017. He had been Chief Executive Officer and President of the Company since 1998. He previously served as Executive Vice President of the Company from 1992 to 1998. He has Board assignments within a number of companies within the William Demant group and partly owned companies, including Chairman of the Boards of Jeudan AS, Ossur hf., Vision RT Ltd., Founders AS and HIMPP AS as well as Board Member of Boston Holding AS and Sennheiser Communications AS. He is also CEO of William Demant Invest AS. In addition, he is Chairman of the Board at Nissens AS, and Deputy Chairman of the Board at ABOUT YOU Holding GmbH and KIRKBI AS. He also serves as Chairman of Thomas B. Thriges Fond . He holds a MS degree in Economics from Aarhus Universitet from 1983.
Age: 60  Chairman Since 2017      
45 39 17 73 00

Demant AS Management Efficiency

Demant AS has return on total asset (ROA) of 9.2 % which means that it generated profit of $9.2 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 25.26 % meaning that it generated $25.26 on every $100 dollars invested by stockholders. Demant AS management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.
The company has accumulated 7.13 B in total debt with debt to equity ratio (D/E) of 100.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Demant AS has Current Ratio of 0.78 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Company Summary

Demant AS, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant AS operates under Medical Instruments Supplies classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 14614 people.Demant AS (DEMANT) is traded on Copenhagen Stock Exchange in Denmark and employs 14,614 people.

Demant AS Leadership Team

Niels Jacobsen, Deputy Chairman of the Board
Thomas Duer, Director, Staff-elected
Peter Foss, Director
Soeren Andersson, Vice President Investor Relations
Rene Schneider, CFO, Member of the Executive Board
Joergen Nielsen, Director, Staff-elected
Benedikte Leroy, Independent Director
Soeren Nielsen, President CEO, Member of the Executive Board
Niels Christiansen, Independent Chairman of the Board
Casper Jensen, Director, Staff-elected
Lars Rasmussen, Independent Director

Stock Performance Indicators

Current Sentiment - DEMANT

Demant AS Investor Sentiment

Macroaxis portfolio users are insensible in their opinion about investing in Demant AS. What is your opinion about investing in Demant AS? Are you bullish or bearish?
50% Bullish
50% Bearish

Demant AS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Citigroup and Canadian Imperial Bank. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Investing Opportunities. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page